Etoposide (VP-16), a topoisomerase II inhibitor that effectively induces DNA damage and subsequent apoptosis in hyperactivated immune cells, has been widely used for the treatment of HLH. However, its ...
Blocking this protein can help boost the immune response against cancer cells. These drugs can be used as part of the first treatment for advanced SCLC, along with etoposide and a platinum chemo drug ...